Risk factors for low muscle mass, malnutrition, and (probable-) sarcopenia in adults with or without a history of cancer in the UK Biobank
- Author(s)
- Kiss, N; Prado, CM; Curtis, AR; Abbott, G; Denehy, L; Edbrooke, L; Baguley, BJ; Fraser, SF; Daly, RM;
- Details
- Publication Year 2024-07,Volume 43,Issue #7,Page 1736-1746
- Journal Title
- Clinical Nutrition
- Publication Type
- Research article
- Abstract
- BACKGROUND AND AIMS: Early identification of people at risk of cancer-related malnutrition, low muscle mass (LMM) and sarcopenia is crucial to mitigate the impact of adverse outcomes. This study investigated risk factors associated with LMM, malnutrition and (probable-) sarcopenia and whether these varied in people with or without a history of cancer. METHODS: Participants in the UK Biobank, with or without a history of cancer, who completed the Oxford WebQ at the baseline assessment were included. LMM was estimated from fat-free mass derived from bioelectrical impedance analysis, and low muscle strength from handgrip strength, and used to identify probable or confirmed sarcopenia following the European Working Group on Sarcopenia in Older People 2 definition. The Global Leadership Initiative on Malnutrition criteria were applied to determine malnutrition. Generalised linear models were used to estimate prevalence ratios (PR) for associations between risk factors (clinical, functional, nutritional) and study outcomes. RESULTS: Overall, 50,592 adults with (n = 2,287, mean ± SD 59.7 ± 7.1 years) or without (n = 48,305, mean ± SD 55.8 ± 8.2 years) cancer were included. For all participants (PRs [cancer, without cancer]), slow walking pace (PR 1.85; 1.99), multimorbidity (PR 1.72; 1.51), inflammation (PR 2.91; 2.07), and low serum 25(OH)D (PR 1.85, 1.44) were associated with higher prevalence of LMM, while higher energy intake (PR 0.55; 0.49) was associated with lower prevalence. Slow walking pace (PR 1.54 [cancer], 1.51 [without cancer]) and higher protein intake (PR 0.18 [cancer]; 0.11 [without cancer]) were associated with increased or decreased prevalence of malnutrition, respectively regardless of cancer status. Multimorbidity was the only common factor associated with higher prevalence (PR 1.79 [cancer], 1.68 [without cancer]) of (probable-)sarcopenia in all participants. CONCLUSION: Risk factors for LMM and malnutrition were similar in adults with and without cancer, although these varied between LMM and malnutrition. These findings have implications for the future of risk stratification, screening and assessment for these conditions and the development or modification of existing screening tools.
- Publisher
- Elsevier
- Keywords
- Humans; *Sarcopenia/epidemiology; *Malnutrition/epidemiology; Male; United Kingdom/epidemiology; Risk Factors; Female; *Neoplasms/epidemiology/complications; Middle Aged; Aged; Hand Strength; Biological Specimen Banks; Prevalence; Muscle, Skeletal/physiopathology/pathology; Nutritional Status; UK Biobank; Cancer; Low muscle mass; Malnutrition; Sarcopenia
- Department(s)
- Health Services Research
- Publisher's Version
- https://doi.org/10.1016/j.clnu.2024.05.041
- Open Access at Publisher's Site
https://doi.org/10.1016/j.clnu.2024.05.041- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-08-06 05:29:15
Last Modified: 2024-08-06 05:31:19